GB-3103

N/A

Report date: 2025/01/26 19:02:27
NME

Base Information

Drug NameGB-3103
Drug Alias Namehistone deacetylase inhibitor 3/6 (Translational Genomics Research Institute)GB-3103
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 10 inhibitorsHistone deacetylase 1 degradersHistone deacetylase 3 inhibitors +[4] 
TargetsHistone deacetylase 10Histone deacetylase 1Histone deacetylase 6 +[4] 
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTranslational Genomics Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesTranslational Genomics Research Institute
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A